Insider · CIK 0001618149
Carl Dockery
Files at AYTU (AYTU BIOPHARMA, INC). First filing -, latest -.
In brief
Carl Dockery files SEC Form 4 as director at AYTU (AYTU BIOPHARMA, INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Carl Dockery has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 28, 2026 | AYTU AYTU BIOPHARMA, INC | AGrant or award Common Stock | +10,000 | $0.00 | $0 | 31,152 | Jul 30, 2026 |
| Oct 3, 2025 | AYTU AYTU BIOPHARMA, INC | AGrant or award Common Stock | +10,000 | $0.00 | $0 | 20,440 | Oct 7, 2025 |
| Nov 6, 2024 | AYTU AYTU BIOPHARMA, INC | AGrant or award Common Shares | +1,500 | $0.00 | $0 | 10,440 | Nov 8, 2024 |
Questions about Carl Dockery
Answered from the filings on this page, as of the latest one.
Is Carl Dockery buying or selling?
Carl Dockery has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Carl Dockery's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Carl Dockery has 0.
Where does Carl Dockery file Form 4?
Carl Dockery has filed Form 4 at AYTU (AYTU BIOPHARMA, INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.